Dr. Ernest P. Bouras, MD

Dr. Bouras practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Bouras' NPI, 1750370623, was assigned on October 13, 2005. Dr. Bouras graduated from Duke University School Of Medicine in 1992. Dr. Bouras holds Florida license ME68279.

Dr. Bouras' primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Bouras' primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bouras practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Bouras' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Bouras is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Bouras' licenses on file in 5 states: Florida, Georgia, Minnesota, South Carolina and North Carolina.

Dmand AI lists acid reflux, colonoscopy, gastrointestinal bleeding, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Bouras treats.

CMS data shows 584 Medicare services from Dr. Bouras across 15 procedure codes in 2024, for 406 Medicare patients. Medicare paid $80,835 for them.

CMS counts 406 Medicare patients who saw Dr. Bouras in 2024. The largest group is 65 to 74, with 220 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bouras' median patient age at 55, with 66% women.

In 2024, Dr. Bouras wrote 29 Medicare Part D claims for 25 patients. 90% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $282 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Bouras for performance year 2024, reported as part of a group. Dr. Bouras accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bouras as offering telehealth. CMS counts 125 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Bouras, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 42 papers to Dr. Bouras, published from 2005 to 2021. 2015 was the busiest year, with 3. The most frequent topics are Antidepressive Agents, Tricyclic, Double-Blind Method and Dyspepsia. Dr. Bouras has published most often in Am J Physiol. Dr. Bouras' most frequent co-authors are Kenneth R. Devault, MD, Massimo Raimondo, MD and Michael B. Wallace, MD.

Dmand AI links Dr. Bouras to 1 clinical trial. Conditions studied include Dyspepsia and Abdominal Pain.

CMS Open Payments shows 1 general payment to Dr. Bouras from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Aries Pharmaceuticals, Inc. paid the most, $17.

Dr. Bouras graduated from Duke University School Of Medicine in 1992.

Dr. Bouras is in network with 8 carriers, including Excellus BlueCross BlueShield, Elevance and Blue Cross Blue Shield of Michigan. POS plans come from the most carriers, 5. Check the plan with the practice before a visit.